Thank you for your welcome. Going over the April 19 PR, it sounds like the company is indirectly announcing that the Welch unit needs work so they brought a microbiologist, Dr. Gazenko, on board. He will attempt to make the Welch hydrogen production unit more efficient. The unit was supposed to begin production at the beginning of April, but the PR tells me that the company is not satisfied with the results. Gazenko will have to go back to the lab to solve the production problems. Personally, I don't expect to see another PR until Gazenko has given the company an idea how long it will take him to fix the problem. Once they can show commercial viability, NNLX should take off.
One thing that is apparent is the seriousness of this company. They really want to be successful. A move to the OTC BB is a big step. I'll be putting more money into NNLX when I see a new base forming.
News 
Market Data 
Discover 
AI
